TVTX
Travere Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$52.42
+6.09%Leverage
- Debt / equity
- 27.28x
- Net debt / equity
- 21.81x
- Debt / assets
- 0.73x
- Debt / EBITDA
- -6.28x
- Net debt / EBITDA
- -5.02x
Liquidity & coverage
- Current ratio
- 3.00x
- Quick ratio
- 2.95x
- Cash ratio
- 2.24x
- Interest coverage
- -15.05x
- EBITDA / interest
- -11.06x
- Working capital
- $422.5M
Cash & dividend
- FCF / debt
- 0.22x
- Cash flow / debt
- 0.29x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Sep 1, 2026